Lymphoma
How Do Mental Health Disorders Affect Survival Among Patients With Lymphoma?
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
How Do Mental Health Disorders Affect Survival Among Patients With Lymphoma?
Dietary Intervention for Improvement of Side Effects Among DLBCL Survivors
Risk of ALCL Following Postmastectomy Implant Reconstruction
ASH 2022: Re-evaluating the Standard of Care in Mantle Cell Lymphoma
NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas (Version 3.2022)
ASTRO 2022: A Novel Approach for Radiotherapy in Orbital Indolent B-Cell Lymphoma
Anaplastic Large-Cell Lymphoma of the Breast: Incidence in the United States
Trends in Improvements in Survival Among Patients With DLBCL
Trends in Cutaneous T-Cell Lymphoma Incidence in the United States
Real-World Outcomes With Axicabtagene Ciloleucel Therapy for Large B-Cell Lymphoma
Characteristics of Advanced Extranodal Natural Killer/ T-Cell Lymphoma and its Treatment
Results From Large Real-World Cohorts on Treatment Outcomes in Patients With Mantle Cell Lymphoma
ASCO 2022: Ibrutinib Added to Bendamustine/Rituximab for Older Patients With Mantle Cell Lymphoma
CAR T-Cell Therapy: Rates of Rehospitalization and Emergency Department Visits Postinfusion
Innate Cell Engager AFM13 Plus Natural Killer Cells for Lymphoma
Immune Responses Among Patients With B-Cell Malignancies Post–COVID-19 Vaccination
Polatuzumab Vedotin-piiq Plus R-CHP vs R-CHOP in Previously Untreated DLBCL: POLARIX Trial
Using PET Scans to Direct Therapy Decisions in Advanced Hodgkin Lymphoma
Mosunetuzumab for Relapsed or Refractory Aggressive and Indolent B-Cell Non-Hodgkin Lymphomas
Emerging Therapies and Current Unmet Needs for Patients With Relapsed or Refractory DLBCL